Europe – New reports address generics pricing, innovation in the EU

A European generics trade association is calling for relaxation of “extreme cost containment policies” against generic medicines, asserting that such measures are counterproductive and may endanger the supply chain through consolidation of production and withdrawal or products from the market.

“The European Commission has collected a growing body of evidence showing that extreme cost containment policies applied to generic medicines are counterproductive, driving industrial consolidation and supply risks and potential medicine withdrawals from the market for important older, less expensive medicine,” wrote Medicines for Europe in a 26 November press release.

The trade association’s statement calls for these considerations to be folded into the EU Transparency Directive and the Public Procurement Directive, which govern pricing and reimbursement, and tendering of medications, respectively…